• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Rhabdomyosarcoma

Rhabdomyosarcoma - 25 Studies Found

Completed : Proton RT for the Treatment of Pediatric Rhabdomyosarcoma
: Rhabdomyosarcoma
: 2007-12-28
: Radiation: Proton Beam Radiation Once per day, 5 days a week for a total of 4 to 6 weeks.
Completed : Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
: Rhabdomyosarcoma
: 2013-05-30
:
  • Drug: Vincristine

Completed : Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma : International Randomized Trial
: RHABDOMYOSARCOMA
: 2011-05-16
:
  • Drug: Vincristine, Irinotecan

Completed : Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma
:
  • Rhabdomyosarcoma
  • Rhabdomyosarcoma-
    : 2017-02-02
    :
    • Drug: Dasatinib Once daily on

Completed : Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma
:
  • Alveolar Childhood Rhabdomyosarcoma
  • Childhood Rhabdomyosarcoma
    : 2006-06-19
    : Drug: doxorubicin, cytoxan
Active, not recruiting : A Study Comparing Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
:
  • Rhabdomyosarcoma
  • Melanoma

: 2015-07-24
:
  • Drug: Tc99m tilmanocept A sing

Active, not recruiting : Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
:
  • Adult Rhabdomyosarcoma
  • Embryonal Childhood
  • Procedure: conventional surgery

Terminated : Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood
:
  • Rhabdomyosarcoma
  • Malignant Soft Tissue

: 2005-09-09
: Drug: Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposide
Completed : Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma
:
  • Alveolar Childhood Rhabdomyosarcoma
  • Embryonal Childhood : 2012-05-30
    : Other: laboratory biomarker analysis Correlative studies
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.